Candotti D, Chaar M.EI, Allain JP. Transfusion transmission of hepatitis B virus: still learning more about it. ISBT Science Series 2011; 6(1): 234-40.
Zhang JM, Xu Y, Wang XY, Yin YK, Wu XH, Weng XH, et al. Coexistence of hepatitis B surface antigen (HBsAg) and heterologous subtype-specific antibodies
to HBsAg among patients with chronic hepatitis B virus infection. Clin Infect Dis 2007; 44(9): 1161-9.
Weber B. Genetic variability of the S gene of hepatitis B virus: clinical and diagnostic impact. J Clin Virol 2005; 32(2): 102-12.
Chen DS. From hepatitis to hepatoma: Lessons from type B viral hepatitis. Science 1993; 262(5132): 369-70.
Sharifi-Mood B, Sanei-Moghaddam E, Ghasem-Zadeh I, Khosravi S. Occult hepatitis B virus infection among anti-HBc only positive individuals in the Southeast of Iran in high prevalence of HBV infection region. Iran Red Crescent Med J 2009; 11(1): 90-2.
Salehi M, Sanei-Moghaddam E, Khosravi S. Seroepidemiological study of HBV and HCV infection in the total population of Zahedan region, Iran.
Zahedan Journal of Research in Medical Sciences 2005; 1: 63-9. [Article in Farsi]
Alizadeh Z, Sharifi Z, Samiei Sh. Prevalence of anti-HBc and anti-HBs in HBsAg negative. Sci J Iran Blood Transfus Organ 2008; 5(3): 139-47. [Article in Farsi]
1Blood Transfusion Research Center, High Institute for Research and Education in Transfusion Medicine, Tehran, Iran 2Faculty of Paramedical Sciences, Shahid Beheshti University of Medical Sciences, Tehran, Iran 3Faculty of Medical Sciences, Tarbiat Modares University, Tehran, Iran 4Zahedan Regional Educational Blood Transfusion Center, Zahedan, Iran
Abstract Background and Objectives
The most common marker used for HBV infection diagnosis in blood donors is screening for HBsAg. The failure of HBsAg detection in blood donors cause of either the window period, or the mutation in S gene, or the reduction in the antigen synthesis can lead to transfusion-transmitted HBV in blood recipients. There have been reported hepatitis cases following the transfusion of anti-HBc positive blood and blood components. The prevalence of anti-HBc in populations is proportional to the prevalence of HBsAg. It is better then for studies about the prevalence of anti-HBc to be conducted in HBV highly prevalent regions. Thus, the aim of this study was to survey anti-HBc and anti-HBs prevalence rates in blood donors in Sistan-o-Baluchestan.
Materials and Methods
In this cross-sectional study, 1500 HBsAg negative samples were collected from Sistan-o-Baluchestan and tested for anti-HBc. All anti-HBc positive samples were tested for anti-HBs. All data were analyzed statistically using Chi-square test.
Results
Out of 1500 blood donors who were negative for HBsAg, 144 (9.6%) were positive for anti-HBc with 74.3% having the immunity titer of anti-HBs.
Conclusions
In this study, the prevalence rate of anti-HBc was very high. Most of anti-HBc positive blood donors were positive for anti-HBs. Therefore, screening of blood donors for anti-HBc can limit the storage of blood.
Correspondence: Sharifi Z., PhD of Virology. Associate Professor of Blood Transfusion Research Center, High Institute for Research and Education in Transfusion Medicine.
P.O.Box: 14665-1157, Tehran, Iran. Tel: (+9821) 82052229; Fax: (+9821) 88601555
E-mail: z.sharifi@ibto.ir
Pazoukian M, Sharifi Z, Pourfatholah A, Hamidpour M, Sanei Moghaddam E, Khosravi S. Investigation of anti-HBc and anti-HBs prevalence in HBsAg negative blood donors in Sistan-o-Baluchestan province. Sci J Iran Blood Transfus Organ 2013; 10 (3) :231-238 URL: http://bloodjournal.ir/article-1-792-en.html